Kadant
The 10-second takeaway
For the quarter ended Sep. 29 (Q3), Kadant beat expectations on revenues and crushed expectations on earnings per share.
Compared to the prior-year quarter, revenue grew slightly and GAAP earnings per share grew slightly.
Gross margins grew, operating margins expanded, net margins dropped.
Revenue details
Kadant chalked up revenue of $86.6 million. The two analysts polled by S&P Capital IQ wanted to see a top line of $80.9 million on the same basis. GAAP reported sales were 2.7% higher than the prior-year quarter's $84.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
EPS came in at $0.66. The three earnings estimates compiled by S&P Capital IQ averaged $0.49 per share. GAAP EPS of $0.73 for Q3 were 2.8% higher than the prior-year quarter's $0.71 per share. (The prior-year quarter included -$0.09 per share in earnings from discontinued operations.)
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Margin details
For the quarter, gross margin was 43.4%, 70 basis points better than the prior-year quarter. Operating margin was 11.4%, 130 basis points better than the prior-year quarter. Net margin was 9.8%, 50 basis points worse than the prior-year quarter.
Looking ahead
Next quarter's average estimate for revenue is $80.8 million. On the bottom line, the average EPS estimate is $0.39.
Next year's average estimate for revenue is $328.8 million. The average EPS estimate is $2.06.
Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 167 members out of 180 rating the stock outperform, and 13 members rating it underperform. Among 49 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 48 give Kadant a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Kadant is outperform, with an average price target of $30.67.
- Add Kadant to My Watchlist.